Gross Margin

French flavor giant posts strong 2025 results despite currency woes, fueled by booming emerging markets and a deep commitment to natural, sustainable ingredients.

Datasea's profits are booming despite a revenue drop, as it pivots to high-margin AI and futuristic acoustic tech. Is this a genius move or a risky gamble?

A new report says cutting streaming can get you a home in years. But does this advice ignore a broken housing market? We investigate the real path to a down payment.

Align Partners launches a major governance overhaul campaign at Dentium, aiming to fix the 'Korea discount' and unlock value at the undervalued market leader.

A new drug, JIN-A02, shows early promise in overcoming resistance to common lung cancer therapies, even shrinking hard-to-treat brain metastases.

The health tech firm posts strong revenue and positive EBITDA, but SEC filings and a falling stock price reveal a more complex and challenging road ahead.

As BJ’s prepares to report Q4 results, investors are watching if a pizza relaunch and new efficiencies can overcome industry-wide cost pressures.

With the hire of elite dealmaker George F. Schoen, the building materials giant is signaling a new era of aggressive M&A and strategic consolidation.

Moody's affirms the Estonian energy giant's Baa3 rating, but a negative outlook signals deep-seated risks from its oil shale legacy and market volatility.

Bio-Techne promotes Steve Crouse to lead its high-growth Diagnostics and Spatial Biology unit, signaling a strategic focus on innovation after a key divestiture.

A surge in healthcare job applications offers a prime opportunity, but new data reveals a critical bottleneck preventing companies from turning interest into hires.

From Millennial micro-cruises to Boomer bucket lists, a new report reveals the deep generational divides reshaping the future of travel and tourism.

Corporate apparel maker Unisync Corp. shifts from loss to profit, boosting margins and securing new deals, proving operational efficiency can trump lower sales.

With key leadership promotions, AscellaHealth aims to streamline the complex path from drug discovery to patient delivery for life sciences companies worldwide.

A Dutch-German gas project powered by offshore wind achieves a top methane certification, offering a new blueprint for Europe's energy transition.

Pharma veteran Pinder Sahota joins digital health firm Reset Health, signaling a strategic shift to integrated care in the new era of weight-loss drugs.

A new report shows the carbon removal market has the tools to fight climate change, but widespread corporate inaction threatens to strand vital projects.

A new report reveals a 38% drop in ransomware, but the danger is evolving. Hackers now prefer silent, long-term intrusion over noisy encryption.

ARS Pharma's neffy challenges the EpiPen with new data on efficacy, cost-effectiveness, and patient preference, promising a less intimidating allergy emergency.

A new survey shows most family firms expect a leadership change soon, but few are prepared, creating a high-stakes gap between intent and action.